GRI Bio, Inc.
GRI
$1.51
-$0.02-1.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.21M | -8.26M | -8.28M | -12.77M | -13.04M |
| Total Depreciation and Amortization | -100.00K | -35.00K | 4.00K | 6.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 943.00K | 2.10M |
| Total Other Non-Cash Items | 194.00K | -120.00K | 88.00K | 281.00K | 259.00K |
| Change in Net Operating Assets | -448.00K | -3.75M | -3.03M | 930.00K | 1.68M |
| Cash from Operations | -8.61M | -12.17M | -11.22M | -10.61M | -8.99M |
| Capital Expenditure | -- | 0.00 | 0.00 | -8.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -8.00K | -8.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 1.44M |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -195.00K |
| Issuance of Common Stock | 13.87M | 11.49M | 10.46M | 17.76M | 12.26M |
| Repurchase of Common Stock | -1.00K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.03M | 1.94M | 2.31M | -3.51M | -2.71M |
| Cash from Financing | 11.83M | 13.43M | 12.77M | 14.25M | 10.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.22M | 1.26M | 1.55M | 3.63M | 1.80M |